Thyroid Cancer A Comprehensive Guide to Clinical Management /
Thoroughly revised and extensively expanded, this encyclopedic, highly acclaimed title addresses all aspects of the etiology, pathogenesis, diagnosis, initial treatment and long-term management of all varieties of thyroid cancer. Expertly edited by Drs. Leonard Wartofsky and Douglas Van Nostrand, th...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2016.
|
| Έκδοση: | 3rd ed. 2016. |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- PART I. General Considerations I: THYROID CANCER
- 1 Anatomy and Physiology of the thyroid gland: Clinical Correlates to Thyroid Cancer
- 2 Epidemiology of Thyroid Cancer
- 3 Molecular Pathogenesis of Thyroid Cancer & Oncogenes in Thyroid Cancer.- 4 Molecular Aspects of Thyroid Cancer in Children
- 5 The Role of Genetics in the Development of Familial Non-Medullary Thyroid Cancer
- 6 Apoptosis in Thyroid Cancer
- 7 Radiation-Induced Thyroid Cancer
- 8 Classification of Thyroid Malignancies.- 9 Staging of Thyroid Cancer
- 10 Recombinant human Thyrotropin (Thyrogen®)
- PART II. GENERAL CONSIDERATIONS II: NUCLEAR MEDICINE
- 11 Radioiodine Whole Body Imaging
- 12 Primer and Atlas for the Interpretation of Radioiodine Whole-Body Scintigraphy
- 13 False-Positive Radioiodine-131 scans in Thyroid Cancer
- 14 The Utility of SPECT-CT in Differentiated Thyroid Cancer
- 15 Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for staging and risk stratification
- 16 Stunning by 131I scanning: Untoward Effect of 131I Thyroid Imaging Prior to Radioablation Therapy
- 17 Stunning is Not a Problem.- 18 Stunning: Does it Exist? A Commentary
- 19 To Perform or Not to Perform Radioiodine Scans Prior to 131I Remnant Ablation?.- PART III. THE THYROID NODULE
- 20 The Thyroid Nodule: Evaluation, Risk of Malignancy, and Management
- 21 Fine-Needle Aspiration
- 22 Diagnostic and Prognostic Molecular Markers in Thyroid Cancer
- 23 Ultrasonic Imaging of the Thyroid Gland.- 24 Radionuclide Imaging of Thyroid Nodules
- 25 18F Fluoro-deoxyglucose PET and Thyroid Nodules
- 26 Thyroid Nodules and Cancer Risk: Surgical Management
- 27 Thyroid Nodules in Children and Cancer Risk
- 28 Management of the Thyroid Nodule: A Comparison Of Published International Guidelines
- PART IV. WELL-DIFFERENTIATED THYROID CANCER A: PAPILLARY CARCINOMA: PRESENTATION
- 29 Papillary Carcinoma: Clinical Aspects
- 30 Papillary Microcarcinoma
- 31 Surgical Approach to Papillary Thyroid Cancer
- 32 Papillary Carcinoma: Cytology and Pathology
- B. INITIAL MANAGEMENT
- 33 Remnant Ablation, Adjuvant Treatment and Treatment of Locoregional Metastases with 131I
- 34 Thyroid Remnant Radioiodine Ablation with Recombinant Human Thyrotropin
- C. SURVEILLANCE
- 35 Follow-up Strategy in Papillary Thyroid Cancer
- 36 Thyroid Hormone Therapy and Thyrotropin Suppression
- 37 Thyroglobulin for Differentiated Thyroid Cancer: Measurement and Interferences.- 38 Thyroglobulin Antibodies and Their Measurement
- 39 Diagnosis of Recurrent Thyroid Cancer in Patients with Anti-Thyroglobulin Antibodies
- 40 Ultrasound of the neck lymph nodes
- 41 Surveillance Radioiodine Whole Body Scans
- 42 Radionuclide Imaging and Treatment of Children with Thyroid Cancer
- 43 Positron Emission Tomography-/Computed Tomography (PET-CT and PET) in Well-Differentiated Thyroid Cancer
- 44 Alternative Thyroid Imaging
- 45 MR and CT Imaging of Thyroid Cancer
- 46 Thyroglobulin in Lymph Node Aspirate
- 47 Management of the Patients with Negative Radioiodine Scan and Elevated Serum Thyroglobulin
- 48 Prognosis in Papillary Thyroid Cancer
- 49 Surgical Management of Lymph Node Metastases.- 50 Utility of Second Surgery for Lymph Node Metastases
- 51 Papillary Cancer Special Aspects in Children
- 52 Special Presentations of Thyroid Cancer in Thyrotoxicosis, Renal Failure, and Struma Ovarii
- 53 Thyroglossal Duct Carcinoma
- 54 Thyroid Cancer in Pregnancy
- D. TREATMENT
- 55 Radiation and Radioactivity
- 56 131I Treatment of Distant Metastases
- 57 Treatment of Metastatic Thyroid Cancer with Radioiodine following preparation by Recombinant Human Thyrotopin
- 58 Dosimetrically-Determined Prescribed Activity of 131I for the Treatment of Metastatic Differentiated Thyroid Carcinoma
- 59 Simplified Methods of Dosimetry
- 60 Radioiodine Dosimetry with Recombinant human Thyrotropin
- 61 The Use of Lithium as an Adjuvant to Radioiodine In the Treatment of Thyroid Cancer
- 62 Side Effects of 131I for Therapy of Differentiated Thyroid Carcinoma.- 63 Radiation Therapy in Papillary Carcinoma
- 64 Chemotherapy of Thyroid Cancer: General Principles
- 65 Bone Metastases from Differentiated Thyroid Carcinoma
- 66 A Summary of Rare Sites of Metastasis Secondary to Differentiated Thyroid Cancer.- 67 Adjunctive Local Approaches to Thyroid Nodules and Metastatic Thyroid Cancer
- 68 Radioiodine-Refractory Thyroid Cancer: Restoring Response to Radioiodine Therapy
- 69 Alternative and Complementary Treatment of Thyroid Disorders
- PART V. WELL-DIFFERENTIATED THYROID CANCER FOLLICULAR CARCINOMA
- 70 Follicular Thyroid Carcinoma
- 71 Surgical Management of Follicular Cancer
- 72 Pathology of Follicular Cancer
- 73 Hürthle Cell Carcinoma
- 74 Follow-Up Strategy in Follicular Thyroid Cancer
- 75 Radionuclide Imaging and 131I Therapy in Follicular Thyroid Carcinoma
- 76 PET/CT in Follicular Cancer Including Hürthle Cell Cancer
- 77 Follicular Thyroid Cancer: Special Aspects in Children and Adolescents
- 78 External Radiation Therapy of Follicular Carcinoma
- 79 Determinants of Prognosis of Follicular Thyroid Carcinoma
- PART VI. VARIANTS OF THYROID CANCER.- 80 Aggressive Variants of Papillary Thyroid Carcinoma and Poorly Differentiated Carcinoma
- 81 Miscellaneous and Unusual Tumors of the Thyroid Gland
- 82 Pathology of Miscellaneous and Unusual Tumors of the Thyroid Gland
- PART VII. UNDIFFERENTIATED TUMORS: MEDULLARY THYROID CARCINOMA
- 83 Clinical Aspects of Medullary Thyroid Carcinoma
- 84 Cytology and Pathology of Medullary Carcinoma
- 85 Medullary Carcinoma of the Thyroid: Surgical Management
- 86 Radionuclide Imaging of Medullary Carcinoma
- 87 PET/CT in Medullary Thyroid Cancer
- 88 Radiation Therapy in Medullary Cancer
- 89 Medullary Carcinoma of the Thyroid: Chemotherapy
- 90 A Comparison of the ATA, NCCN, ETA, and BTA Guidelines for the Management of Medullary Thyroid Cancer
- PART VIII. UNDIFFERENTIATED TUMORS: THYROID LYMPHOMA
- 91 Thyroid Lymphoma
- 92 Pathology of Lymphoma of the Thyroid
- 93 PET/CT in Lymphoma and Lymphoma of the Thyroid
- PART IX. UNDIFFERENTIATED TUMORS: ANAPLASTIC THYROID CANCER
- 94 Anaplastic Thyroid Carcinoma: Clinical Aspects
- 95 Surgical Management of Anaplastic Thyroid Carcinoma
- 96 Pathology of Anaplastic Carcinoma
- 97 PET/CT in Anaplastic Cancer of the Thyroid
- 98 Anaplastic Thyroid Cancer
- 99 Chemotherapy for Anaplastic Thyroid Cancer
- 100 Anaplastic Thyroid Carcinoma: Prognosis
- PART X. NEW FRONTIERS AND FUTURE DIRECTIONS
- 101 Advances in Radiation Therapy
- 102 New Approaches in Nuclear Medicine for Thyroid Cancer
- 103 124I in Differentiated Thyroid Cancer
- 104 Future Directions for Advanced Thyroid Cancer Therapy
- 105 Potential Approaches to Chemotherapy of Thyroid Cancer in the Future
- PART XI. Additional Resources.- 106 Prophylaxis against Radiation Exposure from Radioiodine
- 107 Low Iodine Diets
- 108 Appendix A: Books and Manuals
- 109 Appendix B: Additional Sources of Information: Support groups, Websites and additional information
- 110 Appendix C: Forms and Instructions for Patients Treated with Radioactivity.
